A retrospective cohort study in Veterans with cirrhosis found that giving intravenous albumin after outpatient paracentesis ...

Albumin replacement therapy targeting serum levels ≥ 3.0 g/dL does not improve 90-day survival in patients with septic shock in the emergency department, a trial shows.

The appropriateness of albumin use and baseline albumin usage patterns were studied. Institutional practice patterns regarding the use of albumin were compared to criteria established by an ...

Alphamab Oncology (stock code: 9966.HK) today announced that the first patient has been dosed in the Phase III clinical study (KN026-007) of HER2 bispecific antibody Anbenitamab (KN026) in combination ...

CKD was present in ~26% of adults with type 1 diabetes, yet only ~11% of those with CKD received CKM therapy, indicating persistent treatment gaps and off-label reliance. Treated patients achieved ...

Although previous studies have suggested the potential advantages of albumin administration in patients with severe sepsis, its efficacy has not been fully established. In this multicenter, open-label ...

A research team led by the Leibniz-HKI in Jena has uncovered a new way in which the yeast Candida albicans can damage human tissue. In a study published in Nature Communications, the scientists ...

New York, United States, Jan. 23, 2024 (GLOBE NEWSWIRE) -- The Global Albumin Market Size is to Grow from USD 6.1 Billion in 2022 to USD 9.6 Billion by 2032, at a Compound Annual Growth Rate (CAGR) of ...